ChemoCentryx
CCXI
#3535
Rank
NZ$6.43 B
Marketcap
NZ$89.41
Share price
0.00%
Change (1 day)
33.81%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.25. In 2021 the company made an earnings per share (EPS) of NZ-$3.25 a decrease over its 2020 EPS that were of NZ-$1.39.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-13.51%
2021NZ-$3.25133.33%
2020NZ-$1.39-16.49%
2019NZ-$1.6727.63%
2018NZ-$1.31-305.41%
2017NZ$0.64-142.53%
2016NZ-$1.50-19.44%
2015NZ-$1.86-0%
2014NZ-$1.8613.68%
2013NZ-$1.63-16.67%
2012NZ-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.15-689.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.34-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.11-226.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.64-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.90-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.57-486.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.11-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.48-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.13-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel